Literature DB >> 19255150

Quality of life in patients with leber hereditary optic neuropathy.

Matthew Anthony Kirkman1, Alex Korsten, Miriam Leonhardt, Konstantin Dimitriadis, Ireneaus F De Coo, Thomas Klopstock, Philip G Griffiths, Gavin Hudson, Patrick F Chinnery, Patrick Yu-Wai-Man.   

Abstract

PURPOSE: Leber hereditary optic neuropathy (LHON) is an inherited mitochondrial optic neuropathy characterized by bilateral, severe loss of central vision. In this study, the first formal assessment was conducted of visual disability in affected and unaffected individuals from molecularly confirmed LHON pedigrees.
METHODS: Four hundred two LHON carriers--196 affected and 206 unaffected--from 125 genealogically distinct pedigrees were prospectively interviewed using the well-validated visual function index (VF-14) questionnaire: m.3460G>A (n = 71), m.11778G>A (n = 270), and m.14484T>C (n = 61).
RESULTS: The mean age of onset of visual loss was 27.9 years (SD, 14.9) and mean disease duration was 15.5 years (SD, 15.4), with 74.5% of the affected subjects being men. The mean VF-14 score was 25.1 (SD, 20.8) in the affected patients, compared with 97.3 (SD, 7.1) in the unaffected carriers. Within the affected group, VF-14 score did not worsen with increasing disease duration and individuals with the m.14484T>C mutation had higher VF-14 scores compared with those in the m.3460G>A and m.11778G>A groups. Reading small print and reading a newspaper or book were the two VF-14 items that presented the greatest difficulty.
CONCLUSIONS: LHON has a severe negative impact on quality of life and has the worst VF-14 score when compared with other previously studied ophthalmic disorders. However, affected LHON carriers can be reassured that their level of visual impairment is unlikely to progress with time. The VF-14 questionnaire will be a useful tool for assessing the natural history of LHON and measuring outcome in future treatment trials.

Entities:  

Mesh:

Year:  2009        PMID: 19255150     DOI: 10.1167/iovs.08-3166

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  33 in total

1.  [Leber's hereditary optic neuropathy].

Authors:  B Leo-Kottler; B Wissinger
Journal:  Ophthalmologe       Date:  2011-12       Impact factor: 1.059

Review 2.  Maternally inherited mitochondrial respiratory disorders: from pathogenetic principles to therapeutic implications.

Authors:  Martine Uittenbogaard; Anne Chiaramello
Journal:  Mol Genet Metab       Date:  2020-06-27       Impact factor: 4.797

3.  Leber's hereditary optic neuropathy (LHON) in an Apulian cohort of subjects.

Authors:  Angelica Bianco; Luigi Bisceglia; Paolo Trerotoli; Luciana Russo; Leonardo D'Agruma; Silvana Guerriero; Vittoria Petruzzella
Journal:  Acta Myol       Date:  2017-09-01

4.  Visual function in chronic Leber's hereditary optic neuropathy during idebenone treatment initiated 5 to 50 years after onset.

Authors:  Berthold Pemp; Karl Kircher; Andreas Reitner
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2019-09-03       Impact factor: 3.117

Review 5.  Mitochondrial optic neuropathies - disease mechanisms and therapeutic strategies.

Authors:  Patrick Yu-Wai-Man; Philip G Griffiths; Patrick F Chinnery
Journal:  Prog Retin Eye Res       Date:  2010-11-26       Impact factor: 21.198

Review 6.  Is there treatment for Leber hereditary optic neuropathy?

Authors:  Jason H Peragallo; Nancy J Newman
Journal:  Curr Opin Ophthalmol       Date:  2015-11       Impact factor: 3.761

7.  The m.11778 A > G variant associated with the coexistence of Leber's hereditary optic neuropathy and multiple sclerosis-like illness dysregulates the metabolic interplay between mitochondrial oxidative phosphorylation and glycolysis.

Authors:  Martine Uittenbogaard; Christine A Brantner; ZiShui Fang; Lee-Jun Wong; Andrea Gropman; Anne Chiaramello
Journal:  Mitochondrion       Date:  2018-06-08       Impact factor: 4.160

Review 8.  Treatment of hereditary optic neuropathies.

Authors:  Nancy J Newman
Journal:  Nat Rev Neurol       Date:  2012-09-04       Impact factor: 42.937

9.  Idebenone: A Review in Leber's Hereditary Optic Neuropathy.

Authors:  Katherine A Lyseng-Williamson
Journal:  Drugs       Date:  2016-05       Impact factor: 9.546

10.  Clinical utility gene card for: inherited optic neuropathies including next-generation sequencing-based approaches.

Authors:  Neringa Jurkute; Anna Majander; Richard Bowman; Marcela Votruba; Stephen Abbs; James Acheson; Guy Lenaers; Patrizia Amati-Bonneau; Mariya Moosajee; Gavin Arno; Patrick Yu-Wai-Man
Journal:  Eur J Hum Genet       Date:  2018-08-24       Impact factor: 4.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.